Meaningful Use Stage 2 and 3 Comment Period Comes to a Close

March 3, 2011
On 2/25/2011, the HIT Policy Committee closed the comment period on Meaningful Use stage 2 and 3 standards.  

A few of the measures apply directly to what many Pharmacy Informatics professionals are dealing with today, including:

1.  CPOE for med orders – This objective is still fairly easy to obtain if you have any manner of CPOE in place.  It only requires 1 med order for 80% of patients to be electronically entered (not transmitted)

2.  Drug-drug/drug- allergy interaction checks – lack of standards among data vendors, as well as practice differences makes this one very difficult.  Luckily there are no real measurements, save stating they must be enabled on “appropriate evidence-based interactions”.  I am assuming the interpretation of “appropriate” is up to the individual institution.  

3.  ePrescribing - Stage 3 is proposed at 80% of outpatient and discharge prescriptions.  Depending on current levels of adoption, this could be difficult.  

4.  Maintain active medication list – This is somewhat ironic, requiring 80% of medication lists to be up to date.  The irony entails the fact that most often the longer institutions have been live with physicians managing medication lists, the more inaccurate they become.  Therefore those adopting closer to the stage 3 requirements will actually have cleaner lists, unless major cleanup efforts are undertaken.  A great deal of work is ahead of institutions that have been live for years.  Of course we can interpret the “up to date” requirement to mean someone has looked at it, but personally I would take it one step further and state it must be both accurate and up to date.  

5.  Maintain active med allergy list - Similar to #4, this objective gets worse the longer you are live, unless corrective measures are in place.  Not to mention the lack of standardized allergy nomenclature in information systems.  I apply the same comments regarding “up to date” as in #4.  

6.  Implement drug formulary checks – ePrescribing is becoming more common at facilities, but as we have seen in recent commentary, it still presents a standards challenge.  If you would like a copy of Mark Siska’s wonderful comments on ePrescribing in general, please email me.  

7.  [NEW] Inpatient med orders are tracked via eMAR - The proposed stage 3 requirement includes 80% of medication orders.  Take into consideration floor stock items, flushes, and those that even currently use eMAR may have to do some work to meet the requirement.  For those that still print paper Medication Administration Records, start talking with your IT department now.  

8.  Patient centered electronic access to medical information – Although not directly related to medication, Personal Health Records currently allow for medication lists to be viewed.  When you implement patient portals, be sure to work with your IT department to review the accuracy and usability of the medication information shown.  

9.  Medication Reconciliation – In Stage 3 the requirement rises to 80% for transitions of care.  The interesting verbiage here places the burden on the receiving provider during a transition of care, not the sending provider.  Some system re-engineering may have to take place if EHRs only support the latter.  

10.  Immunization data submitted to IIS –  Immunization records can be difficult to tame, and transmission of data entails some data quality measures to keep things in order.  Like # 3 and 4, the longer lists have been allowed to be populated without quality monitoring, the more cleanup required.  


Overall, the progression of objectives is fully supported by this Informatics Pharmacist.  However, the lack of standardization, challenges of EHR workflow in practice, and shear amount of work needed to meet the requirements is daunting.  Best of luck to us all, but we can certainly agree we are headed in the right direction.  

MU_Stage 2_RFC _2011-01-12_final.pdf View this on Posterous

Wave goodbye

August 5, 2010
http://mashable.com/2010/08/04/rip-google-wave/

To Google Wave. The concept was lots of fun, but we are a society of email. I fear only Apple will be able to beat enough sense into the masses to migrate from its grasp.

Thanks to Mashable for the story, and thanks to Google for trying something exciting.

Twenty-one criteria for a successful CPOE adoption

June 24, 2010
A very nice list from a seasoned CPOE. No ornate study design or data to validate, just good old experience. While this does not always work in healthcare, the list parallels many of the experiences I have had as well. http://histalk2.com/2010/06/23/cio-unplugged-62310/

Thanks to Histalk for the great piece. In my experience, culture is one of the most challenging.

Lexi-Comp not so Compromising

May 27, 2010
If you are planning on dropping a few hundred dollars on Lexi-Comp’s suite of drug and medical information databases, read this first.  Some of you may not be aware, but there are two hidden “features” of the subscription.  I say hidden because they are in fact fine print, but not very intuitive.  FIrst I should mention Lexi-Comp has been my gold standard for medication information over the past 2 years.  They provide referenced, frequently updated information to subscribers.  I use the Lexi-Complete product, which offers over 14 databases.  

The two features I ran into were:

1.  Inability to access databases the DAY after the subscription is set to expire.  Unlike a nice book, once your subscription runs out the data is no longer yours.  No access at all.  I was hoping to just get access without any updates.  I guess in my mind the subscription covers updates to the information, and that is the main motivation for using a digital version over print.  Sorry Lexi-Comp, but I do not agree with your defin

2.  One subscription, one device.  So I was ok with #1, because in previous years I was able to pay one time (albeit hundreds of dollars) and put it on 2 devices.  After calling Lexi-Comp Support, they claim that was bug, and I violated the terms of use.  So this year after dropping just over $500 for a 2+ year subscription, they inform me that I will need to drop an additional $500 to get the same program on a device that is sitting right next to my iPhone on my desk in front of me.  No thank you.  

Sorry Lexi-Comp, but I do not agree with your definition of subscription, nor your idea of digital rights management.  You should review some of the more established online content distribution models, such as http://www.audible.com/ .  They charge per year, but you can put the digital content on multiple devices, and it always stays on your computer.  The agrument that you are a medical information vendor and Audible is a book vendor won’t fly with me either.  Last time I checked both companies sell print and digital versions of their products.

As a result, I cancelled my subscription before the $500 expense had time to hit my wallet.  Money well saved.  

How do you feel about drug information software for mobile and desktop devices?  

iPad: One million and counting

May 4, 2010
http://tech.fortune.cnn.com/2010/05/03/apple-28-days-1-million-ipads/

Apple has sold over 1 million iPads in less than a month.  I have not seen any statistics, but I would bet my 3G iPad that no other tablet type computer has even come close.  

Source:  Company Reports via forbes.com

It is absolutely astounding.  I received my iPad 3G from our reliable friends at Fedex on Friday.  It really has been a magical device to use.  I find myself grabbing it to show the kids and wife things at home (math problems, netflix queues, pdf articles, etc)  and as a quick lookup tool in meetings at work.  Magic aside, I am very interested to see how this device makes my life more productive and fun.  

Drug manufacturer sued for making larger than necessary vials

April 22, 2010

As reported on ASHP NewsLink (http://www.ashp.org/newslinks):

http://www.lvrj.com/news/doctor-in-endoscopy-trial-testifies-vials-of-sedative-were-too-large-91684569.html

Teva pharmaceuticals is being sued because they make a 50ml vial of propofol, and a physician’s poor practice lead to Hepatitis C contamination.  Amazing.  The physician chooses to reuse part of a 50ml vial of propofol and it ends up giving the next patient Hep C. 

Next we will have lawyers suing car manufacturers because a person decided drive under the influence, claiming the car manufacturer makes it too easy for people to grab their keys after drinking excessively (recommending they should add a security device to the car that checks blood alcohol before entry). 

Without a doubt the physician that allowed reuse of the vial should be reprimanded.  I just don’t see the manufacturer as being liable.  What are your thoughts?

CONFIDENTIALITY NOTICE: If you have received this e-mail in error, please immediately notify the sender by return e-mail and delete this e-mail and any attachments from your computer system. To the extent the information in this e-mail and any attachments contain protected health information as defined by the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), PL 104-191; 45 CFR Parts 160 and 164; or Chapter 181, Texas Health and Safety Code, it is confidential and/or privileged. This e-mail may also be confidential and/or privileged under Texas law. The e-mail is for the use of only the individual or entity named above. If you are not the intended recipient, or any authorized representative of the intended recipient, you are hereby notified that any review, dissemination or copying of this e-mail and its attachments is strictly prohibited. 

How effective is healthcare technology so far?

April 20, 2010
Two very exciting articles were published this month in the Journal of Health Affairs:

This study uses data mining to gain a sample size of 2.952 hospitals.  The hospitals either had a Comprehensive EHR, a Basic EHR, or no EHR.  The key measures were risk adjusted length of stay (ALOS), risk adjusted 30 day readmission rates, and risk adjusted inpatient costs.  The staggering and sobering results show there was no difference between EHR and non EHR facilities on quality measures such as AMI, CHF, and pneumonia.  In addition, there were no differences with ALOS for the most part (pneumonia showed a minor decrease with EHR – 0.5 days), no difference with 30 day readmission rates, and no difference with risk adjusted total costs.  What are we spending billions on again?  

This study looked at the 62 hospitals participating in The Leapfrog Group for Patient Safety  CPOE analysis tool.  It found that systems caught drug-allergies in most cases, but did poorly at drug-diagnosis contraindications such as pregnancy.  The interesting measurement was in the prevention of fatal drug doses, where they were only caught in 47% of cases.  In addition, drug-lab and drug-age alerts only flagged appropriately in 21% of cases.  The investigators noted the vendor chosen by the hospital played a statistically significant part in the outcome of testing, suggesting some vendors may build to the leapfrog test or standards.  Systems also seem to do a better job detecting adverse drug events that occur infrequently, as opposed to those that occur frequently.  

These studies parallel some of the results we have seen with Barcoded Medication Administration.  However, in contrast we should consider the stages of adoption in most hospitals.  In the US, we are still trying to learn how to use technology in our daily routines.  Healthcare has been a late player in the game, and the impact on productivity and safety has been minimal.  This is what we should expect.  We need to give healthcare workers time to learn to use the technology to do their daily tasks.  They are still struggling to find where menus are or buttons.  They don’t easily find things they used to flip to in a paper chart.  Once integrated into their workflows, we can start to look at obtaining some real benefits from clinical decision support and interoperability.  Interoperability has a long way to go, so we certainly have time to refine our EHRs for the better.  My final impressions are we need to train more, take ownership of our EHRs and work to improve patient care through their use.  

Navy to implement world’s largest telepharmacy

April 19, 2010
http://www.fiercehealthit.com/press-releases/u-s-navy-pharmacies-improve-pati…

Thanks to FierceHealthIT for catching this announcement. It has huge implications on the retail pharmacy business in the US. The Navy will demonstrate that they can take pharmacists in a central location and have them check prescriptions at remote pharmacies around the world. My guess is businesses like Walgreen’s or Wal-Mart are waiting for approvals to do something similar. Operating pharmacies without having to staff a pharmacist in the physical location could be a huge cost savings, especially in low volume pharmacies. It will be very interesting to see where Class A pharmacies are able to take this.

Hello world!

March 14, 2009

Welcome to WordPress.com. This is your first post. Edit or delete it and start blogging!


Follow

Get every new post delivered to your Inbox.